Paper16633080
Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
Shemyakin A and 5 others. J Cardiovasc Pharmacol, 2006. Cited by 44 papers, by iCite.
Cite this record
ConductScience Library. Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. Papers, record 16633080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16633080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Endothelin A Receptor Antagonists | Major topic |
| Endothelin B Receptor Antagonists | Major topic |
| Endothelium, Vascular | Major topic |
| Insulin Resistance | Major topic |
| Oligopeptides | Major topic |
| Peptides, Cyclic | Major topic |
| Piperidines | Major topic |
| Vasodilation | Major topic |
| Forearm | |
| Humans | |
| Male | |
| Middle Aged | |
| Nitric Oxide Synthase Type III | |
| Regional Blood Flow |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42710913 | Local endothelin-1 receptor type A antagonism improves cutaneous microvascular function in women with a history of gestational diabetes mellitus. | Am J Physiol Heart Circ Physiol | 2026 | https://conductscience.org/library/papers/42710913 | PubMed |
| 35373585 | Dual endothelin receptor antagonism increases resting energy expenditure in people with increased adiposity. | Am J Physiol Endocrinol Metab | 2022 | https://conductscience.org/library/papers/35373585 | PubMed |
| 34966295 | Salt-Sensitivity of Blood Pressure and Insulin Resistance. | Front Physiol | 2021 | https://conductscience.org/library/papers/34966295 | PubMed |
| 31798464 | The Lymphatic System in Obesity, Insulin Resistance, and Cardiovascular Diseases. | Front Physiol | 2019 | https://conductscience.org/library/papers/31798464 | PubMed |
| 31630572 | Chronic Elevation of Endothelin-1 Alone May Not Be Sufficient to Impair Endothelium-Dependent Relaxation. | Hypertension | 2019 | https://conductscience.org/library/papers/31630572 | PubMed |
| 29114220 | Endothelin-1 Regulation of Exercise-Induced Changes in Flow: Dynamic Regulation of Vascular Tone. | Front Pharmacol | 2017 | https://conductscience.org/library/papers/29114220 | PubMed |
| 27789766 | Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1. | J Appl Physiol (1985) | 2017 | https://conductscience.org/library/papers/27789766 | PubMed |
| 25992919 | Vascular Effects of Endothelin Receptor Antagonists Depends on Their Selectivity for ETA Versus ETB Receptors and on the Functionality of Endothelial ETB Receptors. | J Cardiovasc Pharmacol | 2015 | https://conductscience.org/library/papers/25992919 | PubMed |
| 25091502 | Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/25091502 | PubMed |
| 23912930 | Endothelin antagonism and its role in the treatment of hypertension. | Curr Hypertens Rep | 2013 | https://conductscience.org/library/papers/23912930 | PubMed |
| 23900418 | Mechanisms for food polyphenols to ameliorate insulin resistance and endothelial dysfunction: therapeutic implications for diabetes and its cardiovascular complications. | Am J Physiol Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23900418 | PubMed |
| 23397462 | The vascular endothelium in diabetes--a therapeutic target? | Rev Endocr Metab Disord | 2013 | https://conductscience.org/library/papers/23397462 | PubMed |
| 23306778 | Role of insulin resistance in endothelial dysfunction. | Rev Endocr Metab Disord | 2013 | https://conductscience.org/library/papers/23306778 | PubMed |
| 22200728 | The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. | Diabetologia | 2012 | https://conductscience.org/library/papers/22200728 | PubMed |
| 21677282 | Endothelin-1 reduces glucose uptake in human skeletal muscle in vivo and in vitro. | Diabetes | 2011 | https://conductscience.org/library/papers/21677282 | PubMed |
| 21557734 | Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/21557734 | PubMed |
| 21496286 | Effect of the dual endothelin receptor antagonist bosentan on untreatable skin ulcers in a patient with diabetes: a case report. | J Med Case Rep | 2011 | https://conductscience.org/library/papers/21496286 | PubMed |
| 18200806 | Endothelial dysfunction in diabetes mellitus. | Vasc Health Risk Manag | 2007 | https://conductscience.org/library/papers/18200806 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| EDN1 | 1906 | PubTator's text mining | https://conductscience.org/library/genes/1906 | NCBI Gene |
| EDNRA | 1909 | PubTator's text mining | https://conductscience.org/library/genes/1909 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16633080
GET https://conductscience.org/api/papers/v1/16633080/authors